Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer
Brian F. Clem, Julie O'Neal, Gilles Tapolsky, Amy L. Clem, Yoannis Imbert-Fernandez, Daniel A. Kerr, Alden C. Klarer, Rebecca Redman, Donald M. Miller, John O. Trent, Sucheta Telang, Jason Chesney
Dive into the research topics of 'Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer'. Together they form a unique fingerprint.